Immunotherapy is expected to be the ultimate nemesis of malignant glioma
DOI:10.3969/j.issn.1672⁃6731.2020.02.001
Main Author: | Xue⁃jun YANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2020-02-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/2086 |
Similar Items
-
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
by: Haihui Jiang, et al.
Published: (2021-05-01) -
Research progress of adoptive cell therapy in malignant glioma
by: Meng LI
Published: (2016-02-01) -
CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
by: Anna C. Filley, et al.
Published: (2018-10-01) -
Immunotherapy targeting glioma stem cells and its microenvironment
by: Hai⁃yang WANG, et al.
Published: (2020-02-01) -
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
by: Jiayi Zeng, et al.
Published: (2021-10-01)